Alpha-dihydroergocritpine in the treatment of de novo parkinsonian patients: results of a multicenter, randomized, double-blind, placebo-controlled study. - Bergamasco,B.; Frattola,L.; Muratorio,A. (Acta Neurol Scand, 2000)